Lactoferrin and necrotizing enterocolitis

Michael P Sherman1, Mindy M Miller, Jan Sherman

  • 1aDepartment of Child Health bDepartment of Molecular Microbiology and Immunology, School of Medicine cSinclair School of Nursing, University of Missouri, Columbia, Missouri dDivision of Neonatal Medicine, Nemours Children's Hospital, Orlando, Florida, USA.

Insights

Enteral lactoferrin may reduce necrotizing enterocolitis in preterm infants. Breast milk, a natural lactoferrin source, is recommended for extremely preterm infants to potentially lower disease incidence.

Area of Science:

  • Neonatal Medicine
  • Gastroenterology
  • Immunology

Background:

  • Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease in preterm infants.
  • Lactoferrin, a protein found in milk, has demonstrated protective properties.

Purpose of the Study:

  • To review the scientific and clinical evidence on the efficacy of enteral lactoferrin in preventing NEC in preterm infants.
  • To assess the potential of lactoferrin as a therapeutic agent for NEC.

Main Methods:

  • Review of preclinical studies in neonatal rats.
  • Analysis of a multicentered clinical trial involving very low-birth weight preterm infants.

Main Results:

  • Oral lactoferrin reduced bacteremia and mortality in rat models of NEC.
  • Enteral bovine lactoferrin significantly reduced late-onset sepsis in preterm infants.
  • A trend towards diminished NEC incidence was observed in the clinical trial.

Conclusions:

  • Colostrum, rich in lactoferrin, should be given to extremely preterm infants immediately after birth.
  • Continued breastfeeding throughout hospitalization is recommended.
  • Further research is needed to confirm the reduction in NEC prevalence with these practices.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
148
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
63
Inducible Operons: lac Operon01:25

Inducible Operons: lac Operon

The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA...
3.1K